Barclays PLC Dexcom Inc Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Dexcom Inc stock. As of the latest transaction made, Barclays PLC holds 1,280,827 shares of DXCM stock, worth $152 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,280,827
Previous 53,500
2294.07%
Holding current value
$152 Million
Previous $6.64 Million
2575.9%
% of portfolio
0.06%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding DXCM
# of Institutions
1,123Shares Held
352MCall Options Held
4.19MPut Options Held
4.54M-
Vanguard Group Inc Valley Forge, PA44.6MShares$5.3 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY33.9MShares$4.03 Billion0.11% of portfolio
-
State Street Corp Boston, MA16.2MShares$1.93 Billion0.1% of portfolio
-
Baillie Gifford & CO15.7MShares$1.86 Billion1.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA13.4MShares$1.6 Billion0.43% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $45.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...